★ The AEMPS authorizes the phase IIb clinical trial of the Hipra COVID-19 vaccine

© Vidal Vademecum Spain |Cochabamba, 24. 28016 Madrid, Spain - Tel. 91 579 98 00 - Fax: 91 579 82 29 Vademecum.es is officially recognized by the corresponding health authorities as Valid Support to include advertising of prescription drugs or pharmaceutical specialties addressed to health professionals (SVnº09/10-W-CM), granted on December 3, 2010. Warning: The information that appears on this web page is directed exclusively to the professional destined to prescribe or dispense medicines, so it requires a specialized training for its correct interpretation.© Vidal Vademecum Spain | Contact us | Privacy Policy | Legal notice | Cookie Policy | Set preferences Cookies

★ La AEMPS autoriza el ensayo clínico fase IIb de la vacuna frente a la COVID-19 de Hipra